How Latin America Can Avoid a Health Care Misstep

August 23, 2018

When public health emergencies threaten developing nations, governments may look for cheap, fast ways to secure necessary medicine.  One option is compulsory licensing, the topic of a new “Fast Facts” from the Global Alliance for Patient Access.

The Importation Question

July 24, 2018

To import, or not to import?  The question of whether to bring foreign, lower-priced versions of prescription drugs to the United States is back.  

New Video Explains Drug Track-and-Trace Process

February 20, 2018

It might be itching, chills, fatigue or sleeplessness. Side effects are common with prescription drugs. So how do regulators, patients and physicians keep tabs on these events and ensure that drugs are safe in everyday use?

Drug Safety Data Underscores Need for Pharmacovigilance

May 16, 2017

One in every three new drugs triggers side effects discovered only after Food and Drug Administration approval, new data reveals.  And that statistic begs a crucial question: How can we really ensure patients’ safety in an age of sophisticated medications and accelerated approval processes?

WHO Meeting Looks Forward on Distinguishable Names

October 20, 2016

This month’s World Health Organization Open Sessions with INN Stakeholders explored the value, and the future, of the biological qualifier system. The Global Alliance for Patient Access was pleased to present to WHO officials and an international group of fellow stakeholders.